Article
Mediator Tail Module Is Required for Tac1-Activated CDR1 Expression and Azole Resistance in Candida albicans.
Antimicrobial agents and chemotherapy - 1 Nov 2017
Liu Zhongle, Myers Lawrence C
Abstract excerpt
The human fungal pathogen Candida albicans develops drug resistance after long-term exposure to azole drugs in the treatment of chronic candidiasis. Gain-of-function (GOF) mutations in the transcription factor Tac1 and the consequent expression of its targets, drug efflux pumps Cdr1 and Cdr2, are a common mechanism by which C. albicans acquires fluconazole resistance. The mechanism by which GOF mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
